Lungs Home > Revatio for Pulmonary Arterial Hypertension (PAH)
Available only by prescription, Revatio® (sildenafil citrate) is a medication used to improve the ability to exercise and to slow down worsening conditions in adults with pulmonary arterial hypertension (PAH). Revatio comes in tablet or intravenous injectable form and is taken three times daily, with approximately four to six hours between doses.
Although it is not a cure for pulmonary arterial hypertension, Revatio can help to slow down worsening conditions that lead to negative outcomes of the disease, such as lung transplants, the need for additional medications, or even loss of life.
Revatio belongs to a group of medications called phosphodiesterase type-5 (PDE5) inhibitors, and works by causing the blood vessels in the lungs to relax in order to improve blood flow.
(To learn more about using this medication for pulmonary arterial hypertension, click Revatio. This article offers a complete overview of what this disease is, possible causes of it, and how this medication can help improve symptoms.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Revatio [package insert]. New York, NY: Pfizer Inc.;2012 August.
Sildenafil citrate. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2010. Available from Wolters Kluwer Health, Inc. Accessed July 3, 2010.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed July 7, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click